Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway
Elena Campione, Sara Mazzilli, Monia Di Prete, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17

Showing 17 citing articles:

Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression
Oana Mirela Tiucă, Silviu Horia Morariu, Claudia Raluca Mariean, et al.
Life (2024) Vol. 14, Iss. 1, pp. 114-114
Open Access | Times Cited: 9
The causal relationship between serum metabolites and the risk of psoriasis: a Mendelian randomization and meta-analysis study
Yujie Yang, Xuwei Zheng, Haiying Lv, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
DNA methylation patterns in CD4+ T-cells separate psoriasis patients from healthy controls, and skin psoriasis from psoriatic arthritis
Valentina Natoli, Amandine Charras, Sigrun R. Hofmann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management
Mariam Zewail, Haidy Abbas, Nesrine S. El Sayed, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025) Vol. 210, pp. 114692-114692
Closed Access
Genetic Interactions of Phase II Xenobiotic-Metabolizing Enzymes GSTO1 and GCLC in Relation to Alcohol Abuse and Psoriasis Risk
Roman Saranyuk, Olga Bushueva, Ekaterina Efanova, et al.
Journal of Xenobiotics (2025) Vol. 15, Iss. 2, pp. 60-60
Open Access
Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of Dietetics and Clinical Nutrition (ADI), the Italian Society of Dermatology and Sexually Transmitted Diseases (SIDeMaST), the Italian Society of Nutraceuticals (SINut), Club Ketodiets and Nutraceuticals “KetoNut-SINut” and the Italian Society of Endocrinology (SIE), Club Nutrition, Hormones and Metabolism
Luigi Barrea, Ludovica Verde, Giuseppe Annunziata, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access
Therapeutic targeting of p90 ribosomal S6 kinase
Eric B. Wright, Deborah A. Lannigan
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 9
NRF2 in dermo‐cosmetic: From scientific knowledge to skin care products
Marie‐Céline Frantz, Roger Rozot, Laurent Marrot
BioFactors (2022) Vol. 49, Iss. 1, pp. 32-61
Open Access | Times Cited: 13
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis
Mariam Zewail, Haidy Abbas, Nesrine S. El Sayed, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 941-952
Closed Access | Times Cited: 2
Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation
Li Zhang, Xiaoling Liu, Min Huang, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 1403-1413
Open Access | Times Cited: 10
Identification of ADAM23 as a Potential Signature for Psoriasis Using Integrative Machine-Learning and Experimental Verification
Pingping Yao, Yuying Jia, Xuewei Kan, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 6051-6064
Open Access | Times Cited: 6
The association between ACE inhibitors and psoriasis based on the drug-targeted Mendelian randomization and real-world pharmacovigilance analyses
Qiubai Jin, Feihong Ren, Ping Song
Expert Review of Clinical Pharmacology (2023) Vol. 17, Iss. 1, pp. 93-100
Closed Access | Times Cited: 5
The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
Federico Manai, Stefano Govoni, Marialaura Amadio
Cells (2022) Vol. 11, Iss. 24, pp. 4061-4061
Open Access | Times Cited: 9
Topically applied pH-responsive nanogels for alkyl radical-based therapy against psoriasiform hyperplasia
G.R. Nirmal, Chia-Chih Liao, Zih‐Chan Lin, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis
Aleksandra Frątczak, Bartosz Miziołek, Agnieszka Łupicka‐Słowik, et al.
Life (2023) Vol. 13, Iss. 9, pp. 1873-1873
Open Access | Times Cited: 4
Metabolomics analysis reveals cytotoxic effects of ouabain towards psoriatic keratinocytes via impairment of glutathione metabolism
Xuan Zhou, Fei Fei, Wei Song, et al.
Molecular Genetics and Genomics (2023) Vol. 298, Iss. 3, pp. 567-577
Open Access | Times Cited: 1
Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis
Bing Yang, Robert B. Parker, Bernd Meibohm, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0278111-e0278111
Open Access | Times Cited: 1
Real-world use of dimehtyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus
Martina Burlando, Elena Campione, Aldo Cuccia, et al.
Dermatology Reports (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top